Literature DB >> 19563730

Choosing the best contraceptive method for the adult with congenital heart disease.

Candice K Silversides1, Mathew Sermer, Samuel C Siu.   

Abstract

As women with congenital heart disease (CHD) approach childbearing age, issues such as pregnancy and contraception need to be addressed. Women with CHD represent a heterogeneous population. While some have simple cardiac lesions and thus have contraceptive risks that are no different from those of the general population, others have complex, multisystem disease such that incorrect contraception advice can be associated with serious health consequences. Choosing a contraceptive requires consideration of the risk of pregnancy; the available contraception options; their risks, failure rates, and benefits; and the preferences of the woman. This review focuses on contraceptive selection in women with CHD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563730     DOI: 10.1007/s11886-009-0043-7

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  41 in total

Review 1.  Heart disease and pregnancy.

Authors:  S C Siu; J M Colman
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

Review 2.  Pregnancy and contraception in heart disease and pulmonary arterial hypertension.

Authors:  Sara Thorne; Catherine Nelson-Piercy; Anne MacGregor; Simon Gibbs; John Crowhurst; Nick Panay; Eric Rosenthal; Fiona Walker; David Williams; Michael de Swiet; John Guillebaud
Journal:  J Fam Plann Reprod Health Care       Date:  2006-04

3.  ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions.

Authors: 
Journal:  Obstet Gynecol       Date:  2006-06       Impact factor: 7.661

4.  The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization.

Authors:  H B Peterson; Z Xia; J M Hughes; L S Wilcox; L R Tylor; J Trussell
Journal:  Am J Obstet Gynecol       Date:  1996-04       Impact factor: 8.661

5.  Risk of idiopathic venous thromboembolism in users of progestagens alone.

Authors:  C Vasilakis; H Jick; M del Mar Melero-Montes
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

6.  Prospective study of oral contraceptives and hypertension among women in the United States.

Authors:  L Chasan-Taber; W C Willett; J E Manson; D Spiegelman; D J Hunter; G Curhan; G A Colditz; M J Stampfer
Journal:  Circulation       Date:  1996-08-01       Impact factor: 29.690

7.  An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables.

Authors:  Jan Endrikat; C Klipping; M Cronin; C Gerlinger; A Ruebig; W Schmidt; B Düsterberg
Journal:  Contraception       Date:  2002-03       Impact factor: 3.375

8.  Increased prevalence of migraine in Marfan syndrome.

Authors:  Jeroen C Vis; Janneke Timmermans; Martijn C Post; Werner Budts; Marc A A M Schepens; Vincent Thijs; Wouter J Schonewille; Rob M A de Bie; Herbert W M Plokker; Jan G P Tijssen; Barbara J M Mulder
Journal:  Int J Cardiol       Date:  2008-08-03       Impact factor: 4.164

9.  Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

Authors: 
Journal:  Lancet       Date:  1995-12-16       Impact factor: 79.321

10.  Prevalence of "silent" pulmonary emboli in adults after the Fontan operation.

Authors:  Chetan Varma; Matthew R Warr; Aaron L Hendler; Narinder S Paul; Gary D Webb; Judith Therrien
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

View more
  9 in total

Review 1.  Pregnancy After Cardiac Surgery.

Authors:  Anjali Vivek Kanhere; Vivek Madhav Kanhere
Journal:  J Obstet Gynaecol India       Date:  2016-02-08

Review 2.  Monitoring the patient with transposition of the great arteries: arterial switch versus atrial switch.

Authors:  Susan Lucy Roche; Candice Kristine Silversides; Erwin Notker Oechslin
Journal:  Curr Cardiol Rep       Date:  2011-08       Impact factor: 2.931

3.  Safety of contraceptive use among women with congenital heart disease: A systematic review.

Authors:  Ginnie Abarbanell; Naomi K Tepper; Sherry L Farr
Journal:  Congenit Heart Dis       Date:  2019-01-25       Impact factor: 2.007

4.  Counseling reproductive health issues in women with congenital heart disease.

Authors:  Mathias Kaemmerer; Matthäus Vigl; Vanadin Seifert-Klauss; Nicole Nagdyman; Ulrike Bauer; Karl-Theo Maria Schneider; Harald Kaemmerer
Journal:  Clin Res Cardiol       Date:  2012-05-15       Impact factor: 5.460

Review 5.  Pregnancy in women with congenital heart disease.

Authors:  Rohan D'Souza; Mathew Sermer; Candice K Silversides
Journal:  Obstet Med       Date:  2015-02-27

6.  Menstrual Dysfunction and Treatment Among Adolescents With Congenital Heart Disease.

Authors:  Maayan Leroy-Melamed; Amy Katz; Marcia L Shew
Journal:  J Pediatr Adolesc Gynecol       Date:  2020-08-20       Impact factor: 2.046

Review 7.  Pregnancy complicated by valvular heart disease: an update.

Authors:  Michael Nanna; Kathleen Stergiopoulos
Journal:  J Am Heart Assoc       Date:  2014-06-05       Impact factor: 5.501

8.  Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Pediatric Cardiology (SICP), and Italian Society of Gynaecologists and Obstetrics (SIGO): pregnancy and congenital heart diseases.

Authors:  Innocenzo Bianca; Giovanna Geraci; Michele Massimo Gulizia; Gabriele Egidy Assenza; Chiara Barone; Marcello Campisi; Annalisa Alaimo; Rachele Adorisio; Francesca Comoglio; Silvia Favilli; Gabriella Agnoletti; Maria Gabriella Carmina; Massimo Chessa; Berardo Sarubbi; Maurizio Mongiovì; Maria Giovanna Russo; Sebastiano Bianca; Giuseppe Canzone; Marco Bonvicini; Elsa Viora; Marco Poli
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

Review 9.  Cardiovascular Imaging in Pregnancy: Valvulopathy, Hypertrophic Cardiomyopathy, and Aortopathy.

Authors:  Haneen Ismail; Andrew J Bradley; Jannet F Lewis
Journal:  Front Cardiovasc Med       Date:  2022-08-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.